Starbucks' Same-Store Sales Roar Back, But Its Biggest Hurdle Remains

Starbucks posted a strong fiscal Q2 with revenue up 8.8% to $9.53B, adjusted EPS up 22% to $0.50, and global same-store sales growth of 6.2%, beating consensus on both revenue and earnings. North America comparable sales rose 7.1%, helped by traffic growth and menu innovation, while the company raised full-year adjusted EPS guidance to $2.25-$2.45 and sees at least 5% global and U.S. same-store sales growth. The key offset is margin pressure: North American operating margin fell 170bps to 10.2%, keeping profitability the main execution risk despite improving sales momentum.

Analysis

The market is likely still underappreciating how much of this turnaround is being driven by mix and frequency rather than pure pricing power. That matters because traffic-led recovery is more durable than ticket-led recovery, but it also implies margin expansion will lag sales for several quarters: staffing, remodeling, and premium beverage complexity all raise the cost-to-serve before they fully translate into higher throughput. In other words, the demand inflection is real, but the P&L lever is still in the wrong place for a clean multiple re-rating.

The biggest second-order effect is competitive pressure on fast-casual and specialty beverage peers. If Starbucks can keep share gains coming from innovation plus operational fixes, it forces competitors to spend more on promotions and product cadence, especially in cold beverages and breakfast adjacencies. That could compress margins across the broader beverage/snack ecosystem even if unit volumes remain healthy, with the weakest operators seeing the most pressure first.

The China restructuring is a hidden positive for quality, not just headline simplification. Exiting the consolidated reporting of China reduces near-term volatility in disclosed comps and removes a low-visibility drag on sentiment, but it also makes the remaining business look cleaner than the economics really are. The real swing factor over the next 6-12 months is whether North America margin stabilization shows up before guidance resets higher again; if it does not, the stock can remain expensive on improving sales but stagnant earnings power.

Consensus is likely over-indexing on the visible top-line inflection and underweighting the duration of margin repair. The stock can keep working if investors believe 5%+ comp growth is sustainable, but at current valuation the setup is fragile: a modest traffic miss or evidence that labor/remodel investment is not yielding sufficient productivity would be enough to stall multiple expansion. The asymmetry is that upside requires both demand persistence and margin recovery, while downside only needs one of those legs to wobble.

Key Decisions for Investors

• Avoid initiating a fresh long in SBUX at current levels; wait 1-2 quarters for evidence that North America operating margin stabilizes, because the current multiple already discounts a near-perfect turnaround.
• For investors already long SBUX, consider selling covered calls 2-3 months out to monetize elevated valuation while retaining upside if comp momentum persists; this is best if the stock trades sideways on margin skepticism.
• Pair trade: long CMG vs short SBUX over the next 3-6 months. CMG has more room to absorb execution risk into growth, while SBUX is carrying a much heavier burden of proving margin restoration after the sales rebound.
• Use any post-earnings pullback in SBUX to reassess only if North America traffic remains positive and management refrains from overreaching on guidance; otherwise, the risk/reward skews to the downside as execution expectations rise faster than EPS power.
• Watch specialty beverage and breakfast-adjacent names for competitive spillover; if SBUX’s cold beverage launch continues to gain share, expect promotional pressure on peers within 1-2 quarters and position accordingly.